Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer

[1]  D. Hanahan Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[2]  H. Levine,et al.  Quantifying the patterns of metabolic plasticity and heterogeneity along the epithelial-hybrid-mesenchymal spectrum in cancer , 2021, bioRxiv.

[3]  I. Rodriguez-Hernandez,et al.  The amoeboid state as part of the epithelial-to-mesenchymal transition programme. , 2021, Trends in cell biology.

[4]  Shiva Gholizadeh-Ghaleh Aziz,et al.  The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis , 2021, Molecular Biology Reports.

[5]  Beth K. Martin,et al.  Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. , 2021, Cancer cell.

[6]  J. Cheong,et al.  Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial–Mesenchymal Transition Activity States , 2021, Cancers.

[7]  R. DePinho,et al.  Metabolic Codependencies in the Tumor Microenvironment. , 2021, Cancer discovery.

[8]  H. Levine,et al.  A mechanistic modeling framework reveals the key principles underlying tumor metabolism , 2021, bioRxiv.

[9]  E. Morii,et al.  Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis , 2021, Metabolites.

[10]  J. Onuchic,et al.  Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer , 2020, British Journal of Cancer.

[11]  Shubham Tripathi,et al.  Biological Networks Regulating Cell Fate Choice Are Minimally Frustrated. , 2020, Physical review letters.

[12]  A. Rustgi,et al.  EMT, MET, Plasticity, and Tumor Metastasis. , 2020, Trends in cell biology.

[13]  T. Wen,et al.  NRF2, a Transcription Factor for Stress Response and Beyond , 2020, International journal of molecular sciences.

[14]  Haitao Ma,et al.  Low levels of AMPK promote epithelial‐mesenchymal transition in lung cancer primarily through HDAC4‐ and HDAC5‐mediated metabolic reprogramming , 2020, Journal of cellular and molecular medicine.

[15]  M. Jolly,et al.  Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis , 2020, Translational oncology.

[16]  Jin Wang,et al.  Exposing the Underlying Relationship of Cancer Metastasis to Metabolism and Epithelial-Mesenchymal Transitions , 2019, iScience.

[17]  Shiwen Xu,et al.  Chlorpyrifos induced oxidative stress to promote apoptosis and autophagy through the regulation of miR-19a-AMPK axis in common carp. , 2019, Fish & shellfish immunology.

[18]  Jaeseung Yoon,et al.  MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells , 2019, Cellular & Molecular Biology Letters.

[19]  J. Onuchic,et al.  Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response , 2019, Journal of clinical medicine.

[20]  R. Lamont,et al.  Streptococcus gordonii programs epithelial cells to resist ZEB2 induction by Porphyromonas gingivalis , 2019, Proceedings of the National Academy of Sciences.

[21]  J. Onuchic,et al.  Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways , 2019, Proceedings of the National Academy of Sciences.

[22]  H. Harada,et al.  HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance , 2019, International journal of molecular sciences.

[23]  N. Kim,et al.  Therapeutic implications of cancer epithelial-mesenchymal transition (EMT) , 2019, Archives of Pharmacal Research.

[24]  Jingxia Li,et al.  Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer , 2019, Cell adhesion & migration.

[25]  E. Ben-Jacob,et al.  Toward understanding cancer stem cell heterogeneity in the tumor microenvironment , 2018, Proceedings of the National Academy of Sciences.

[26]  L. Jia,et al.  Metastatic cancer cells compensate for low energy supplies in hostile microenvironments with bioenergetic adaptation and metabolic reprogramming. , 2018, International journal of oncology.

[27]  M. Saitoh Involvement of partial EMT in cancer progression. , 2018, Journal of biochemistry.

[28]  Jason T. George,et al.  NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype , 2018, bioRxiv.

[29]  Michael D. Brooks,et al.  Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. , 2018, Cell metabolism.

[30]  Jason T. George,et al.  A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling , 2018, bioRxiv.

[31]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[32]  Michael D. Brooks,et al.  Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling , 2018, Stem cell reports.

[33]  H. Levine,et al.  Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States , 2018, Cells.

[34]  Rafał Bartoszewski,et al.  miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target , 2018, Angiogenesis.

[35]  Mohit Kumar Jolly,et al.  Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric. , 2017, Cancer research.

[36]  C. Frezza,et al.  Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer , 2017, The FEBS journal.

[37]  P. Bertolazzi,et al.  Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines , 2017, Oncotarget.

[38]  X. Zong,et al.  Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression. , 2017, Critical reviews in oncology/hematology.

[39]  Jianpeng Ma,et al.  Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation. , 2017, Cancer research.

[40]  P. Liu,et al.  FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition , 2016, Oncotarget.

[41]  M. Esteller,et al.  Oncometabolite Accumulation and Epithelial-to-Mesenchymal Transition: The Turn of Fumarate. , 2016, Cell metabolism.

[42]  Sendurai A Mani,et al.  Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment? , 2016, Cancer letters.

[43]  Kumari Sonal Choudhary,et al.  EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT , 2016, PLoS Comput. Biol..

[44]  K. Yanagihara,et al.  Impaired mitophagy activates mtROS/HIF-1α interplay and increases cancer aggressiveness in gastric cancer cells under hypoxia. , 2016, International journal of oncology.

[45]  E. Ben-Jacob,et al.  Stability of the hybrid epithelial/mesenchymal phenotype , 2016, Oncotarget.

[46]  J. Locasale,et al.  The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.

[47]  S. Leung,et al.  PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer. , 2015, Cell metabolism.

[48]  Eshel Ben-Jacob,et al.  Coupling the modules of EMT and stemness: A tunable ‘stemness window’ model , 2015, Oncotarget.

[49]  J. Lieberman,et al.  miR-34 and p53: New Insights into a Complex Functional Relationship , 2015, PloS one.

[50]  M. Zeisberg,et al.  Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells* , 2015, The Journal of Biological Chemistry.

[51]  Ying Zhang,et al.  Nrf2 regulates ROS production by mitochondria and NADPH oxidase , 2015, Biochimica et biophysica acta.

[52]  A. Piotrowski,et al.  The hypoxia‐inducible miR‐429 regulates hypoxia‐inducible factor‐1α expression in human endothelial cells through a negative feedback loop , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  Weidong Huang,et al.  AMPK Plays a Dual Role in Regulation of CREB/BDNF Pathway in Mouse Primary Hippocampal Cells , 2015, Journal of Molecular Neuroscience.

[54]  R. Kalluri,et al.  Corrigendum: PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis , 2014, Nature Cell Biology.

[55]  C. Shapiro,et al.  AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis. , 2014, Cancer research.

[56]  T. Copetti,et al.  A mitochondrial switch promotes tumor metastasis. , 2014, Cell reports.

[57]  Eshel Ben-Jacob,et al.  MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.

[58]  E. Ben-Jacob,et al.  Tristability in cancer-associated microRNA-TF chimera toggle switch. , 2013, The journal of physical chemistry. B.

[59]  G. Melino,et al.  Identification of NCF2/p67phox as a novel p53 target gene , 2012, Cell cycle.

[60]  Xueyuan Bai,et al.  miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. , 2011, Journal of the American Society of Nephrology : JASN.

[61]  Harshini Sarojini,et al.  Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1 , 2011, Mechanisms of Ageing and Development.

[62]  J. Hayashi,et al.  ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.

[63]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[64]  E. Hay,et al.  The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[65]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.

[66]  J. Paul,et al.  New Dimensions , 2011 .

[67]  T. Clanton,et al.  Journal of Applied Physiology publishes original papers that deal with diverse area of research in applied , 2007 .